相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel Targeted Therapies for Eosinophil-Associated Diseases and Allergy
Susanne Radonjic-Hoesli et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
Neues von der internationalen Leitlinie für Diagnostik und Therapie der chronischen Urtikaria
Marcus Maurer et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2015)
OX40L blockade and allergen-induced airway responses in subjects with mild asthma
G. M. Gauvreau et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2014)
Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis
Richard B. Moss
EUROPEAN RESPIRATORY JOURNAL (2014)
Length Of Avoidance Period Following Peanut Oral Immunotherapy Influences Effector Cell Suppression and Clinical Outcomes
Michael D. Kulis et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Efficacy and safety of an anti-IL-13 mAb in patients with severe asthma: A randomized trial
Erika H. De Boever et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: A retrospective clinical analysis
Martin Metz et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2014)
Adverse reactions to biologic agents and their medical management
Onur Boyman et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
Effects of an Anti-TSLP Antibody on Allergen-Induced Asthmatic Responses
Gail M. Gauvreau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
Lisa A. Beck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Omalizumab Therapy for Allergic Bronchopulmonary Aspergillosis in Children with Cystic Fibrosis: A Synthesis of Published Evidence
Kalliopi Tanou et al.
PEDIATRIC PULMONOLOGY (2014)
Successful Management of Churg-Strauss Syndrome Using Omalizumab as Adjuvant Immunomodulatory Therapy: First Documented Pediatric Case
E. Iglesias et al.
PEDIATRIC PULMONOLOGY (2014)
Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE production
Gail M. Gauvreau et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Schnitzler's syndrome: diagnosis, treatment, and follow-up
A. Simon et al.
ALLERGY (2013)
Randomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti-IL-17 Receptor Monoclonal Antibody, in Moderate to Severe Asthma
William W. Busse et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Long-term efficacy of fixed-dose omalizumab for patients with severe chronic spontaneous urticaria
Christine Hahjin Song et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2013)
Severe Refractory Atopic Dermatitis in an Adolescent Patient Successfully Treated with Ustekinumab
Anna Agusti-Mejias et al.
ANNALS OF DERMATOLOGY (2013)
Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome
Heleen D. de Koning et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
A phase 1, randomized, placebo-controlled, dose-escalation study of an anti-IL-13 monoclonal antibody in healthy subjects and mild asthmatics
Peter Hodsman et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Safety, tolerability and pharmacokinetics of a human anti-interleukin-13 monoclonal antibody (CNTO 5825) in an ascending single-dose first-in-human study
Bart van Hartingsveldt et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up
K. A. Papp et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Long-Term Follow-Up of Patients With Hypereosinophilic Syndrome Treated With Alemtuzumab, an Anti-CD52 Antibody
Paolo Strati et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2013)
Omalizumab: A Review of its Use in Patients with Severe Persistent Allergic Asthma
Kate McKeage
DRUGS (2013)
A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma
Edward Piper et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Tralokinumab for uncontrolled asthma
Ileana Antohe et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
New era of biologic therapeutics in atopic dermatitis
Emma Guttman-Yassky et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids
Michael Noonan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report
A. Wesley Burks et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes
Florence E. Roufosse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Efficacy and safety of canakinumab in urticarial vasculitis: An open-label study
Karoline Krause et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Anti-IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis
Iris M. Otani et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia
Michel Laviolette et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma
Philippe Gevaert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy
Allen Kaplan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
Dominique Baeten et al.
LANCET (2013)
Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
Marcus Maurer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
Sally Wenzel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Omalizumab in the management of steroid dependent Allergic Bronchopulmonary Aspergillosis (ABPA) complicating Cystic Fibrosis
Rachel Wong et al.
PAEDIATRIC RESPIRATORY REVIEWS (2013)
Transient impact of omalizumab in pollen allergic patients undergoing specific immunotherapy
Matthias Volkmar Kopp et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2013)
Efficacy of Anti-Interleukin-5 Therapy with Mepolizumab in Patients with Asthma: A Meta-Analysis of Randomized Placebo-Controlled Trials
Yao Liu et al.
PLOS ONE (2013)
A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma
Chad K. Oh et al.
RESPIRATORY RESEARCH (2013)
Oral Immunotherapy for Food Allergy: Towards a New Horizon
Evelyne Khoriaty et al.
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2013)
Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study
K. Krause et al.
ALLERGY (2012)
Biologic drugs in autoinflammatory syndromes
Roberta Caorsi et al.
AUTOIMMUNITY REVIEWS (2012)
Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomised, double-blind, placebo-controlled, phase II regimen-finding study
P. Rich et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Successful treatment of systemic cold contact urticaria with etanercept in a patient with psoriasis
G. Gualdi et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor
N. A. Molfino et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2012)
Benralizumab - a humanized mAb to IL-5Rα with enhanced antibody-dependent cell-mediated cytotoxicity - a novel approach for the treatment of asthma
Aasia Ghazi et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Treatment of severe refractory adult atopic dermatitis with ustekinumab
Rafael Puya et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2012)
IL-4 receptor polymorphisms predict reduction in asthma exacerbations during response to an anti-IL-4 receptor α antagonist
Rebecca E. Slager et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Novel targeted therapies for eosinophilic disorders
Michael E. Wechsler et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Reslizumab in children and adolescents with eosinophilic esophagitis: Results of a double-blind, randomized, placebo-controlled trial
Jonathan M. Spergel et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Long-term safety experience of ustekinumab in patients with moderate-to-severe psoriasis (Part I of II): Results from analyses of general safety parameters from pooled Phase 2 and 3 clinical trials
Mark Lebwohl et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
Ian D. Pavord et al.
LANCET (2012)
Marketing approval of mogamulizumab A triumph for glyco-engineering
Alain Beck et al.
MABS (2012)
Changes in antigen-specific T-cell number and function during oral desensitization in cow's milk allergy enabled with omalizumab
D. Bedoret et al.
MUCOSAL IMMUNOLOGY (2012)
Therapies for allergic inflammation: refining strategies to induce tolerance
Cezmi A. Akdis
NATURE MEDICINE (2012)
Innate and adaptive immune responses in asthma
Stephen T. Holgate
NATURE MEDICINE (2012)
The potential of biologics for the treatment of asthma
Girolamo Pelaia et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Brodalumab, an Anti-Interleukin-17-Receptor Antibody for Psoriasis
Kim A. Papp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Effects of Adding Omalizumab, an Anti-Immunoglobulin E Antibody, on Airway Wall Thickening in Asthma
Makoto Hoshino et al.
RESPIRATION (2012)
Allergic bronchopulmonary aspergillosis treated successfully for one year with omalizumab
Jennifer Collins et al.
JOURNAL OF ASTHMA AND ALLERGY (2012)
Omalizumab - an effective and safe treatment of therapy-resistant chronic spontaneous urticaria
A. Groffik et al.
ALLERGY (2011)
Can anti-IgE therapy prevent airway remodeling in allergic asthma?
K. F. Rabe et al.
ALLERGY (2011)
Allergic bronchopulmonary aspergillosis and omalizumab
I. Tillie-Leblond et al.
ALLERGY (2011)
Effects of Interleukin-13 Blockade on Allergen-induced Airway Responses in Mild Atopic Asthma
Gail M. Gauvreau et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Reslizumab for Poorly Controlled, Eosinophilic Asthma A Randomized, Placebo-controlled Study
Mario Castro et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Targeting Interleukin-5 in Refractory and Relapsing Churg-Strauss Syndrome
Frank Moosig et al.
ANNALS OF INTERNAL MEDICINE (2011)
Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy A Randomized Trial
Nicola A. Hanania et al.
ANNALS OF INTERNAL MEDICINE (2011)
Omalizumab: Anti-IgE Therapy in Allergy
Matthias Volkmar Kopp
CURRENT ALLERGY AND ASTHMA REPORTS (2011)
Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial
S. T. Holgate et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Efalizumab
Marina Talamonti et al.
EXPERT OPINION ON DRUG SAFETY (2011)
An Antibody Against IL-5 Reduces Numbers of Esophageal Intraepithelial Eosinophils in Children With Eosinophilic Esophagitis
Amal H. Assa'ad et al.
GASTROENTEROLOGY (2011)
Anti-Immunoglobulin E Treatment of Patients with Recalcitrant Physical Urticaria
Martin Metz et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2011)
A phase II, randomized, double-blind, parallel-group, placebo-controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy
Hugh A. Sampson et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Rituximab successfully treats refractory chronic autoimmune urticaria caused by IgE receptor autoantibodies
Soumya D. Chakravarty et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Future forms of immunotherapy
Thomas B. Casale et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Future therapies for food allergies
Anna Nowak-Wegrzyn et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome
Jan Lotvall et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Rapid oral desensitization in combination with omalizumab therapy in patients with cow's milk allergy
Kari C. Nadeau et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis
Philippe Gevaert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Treatment of refractory chronic urticaria with tumor necrosis factor-alfa inhibitors
Lindsay H. Wilson et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Lebrikizumab Treatment in Adults with Asthma
Jonathan Corren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children
William W. Busse et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Population PK and IgE Pharmacodynamic Analysis of a Fully Human Monoclonal Antibody Against IL4 Receptor
Tarundeep Kakkar et al.
PHARMACEUTICAL RESEARCH (2011)
Airway remodeling in asthma: New mechanisms and potential for pharmacological intervention
Pierre-Olivier Girodet et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Effects of omalizumab in Aspergillus-associated airway disease
L. A. Perez-de-Llano et al.
THORAX (2011)
Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma
Joseph M. Parker et al.
BMC PULMONARY MEDICINE (2011)
Steroid dependency despite omalizumab treatment of ABPA in cystic fibrosis
F. Brinkmann et al.
ALLERGY (2010)
A Randomized, Controlled, Phase 2 Study of AMG 317, an IL-4Rα Antagonist, in Patients with Asthma
Jonathan Corren et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial
A. Straumann et al.
GUT (2010)
B-cell targeted therapies in human autoimmune diseases: an updated perspective
Michael J. Townsend et al.
IMMUNOLOGICAL REVIEWS (2010)
Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor α antibody, in a phase I study of subjects with mild asthma
William W. Busse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Sustained response to mepolizumab in refractory Churg-Strauss syndrome
Jean-Emmanuel Kahn et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
A review of treatment with mepolizumab, an anti-IL-5 mAb, in hypereosinophilic syndromes and asthma
William W. Busse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome
Florence Roufosse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome
Sophia Kim et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma
Marc Massanari et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Efalizumab for severe refractory atopic eczema: retrospective study on 11 cases
K. Ibler et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2010)
Safety of anti-IgE treatment with omalizumab in children with seasonal allergic rhinitis undergoing specific immunotherapy simultaneously
Wolfgang Kamin et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2010)
Italian real-life experience of omalizumab
M. Cazzola et al.
RESPIRATORY MEDICINE (2010)
The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis
Daniel E. Furst
SEMINARS IN ARTHRITIS AND RHEUMATISM (2010)
How are TH2-type immune responses initiated and amplified?
William E. Paul et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Effects of omalizumab on markers of inflammation in patients with allergic asthma
S. Holgate et al.
ALLERGY (2009)
Prolonged high-dose omalizumab is required to control reactions to venom immunotherapy in mastocytosis
K. Kontou-Fili et al.
ALLERGY (2009)
A Randomized, Double-blind, Placebo-controlled Study of Tumor Necrosis Factor-α Blockade in Severe Persistent Asthma
Sally E. Wenzel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials
C. Salliot et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma
M. V. Kopp et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2009)
Alemtuzumab Therapy for Hypereosinophilic Syndrome and Chronic Eosinophilic Leukemia
Srdan Verstovsek et al.
CLINICAL CANCER RESEARCH (2009)
Two First-in-Human, Open-Label, Phase I Dose-Escalation Safety Trials of MEDI-528, a Monoclonal Antibody Against Interleukin-9, in Healthy Adult Volunteers
Barbara White et al.
CLINICAL THERAPEUTICS (2009)
Re-Treatment with Omalizumab at One Year Interval for Japanese Cedar Pollen-Induced Seasonal Allergic Rhinitis Is Effective and Well Tolerated
Satoshi Ogino et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2009)
Therapy of autoinflammatory syndromes
Hal M. Hoffman
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Anti-CD20 or anti-IgE therapy for severe chronic autoimmune urticaria
Peter D. Arkwright
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
DRUG THERAPY Asthma
Christopher H. Fanta
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
Pranabashis Haldar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
Parameswaran Nair et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Structure and signalling in the IL-17 receptor family
Sarah L. Gaffen
NATURE REVIEWS IMMUNOLOGY (2009)
High omalizumab dose controls recurrent reactions to venom immunotherapy in indolent systemic mastocytosis
K. Kontou-Fili
ALLERGY (2008)
Successful treatment of solar urticaria with anti-immunoglobulin E therapy
O. Guezelbey et al.
ALLERGY (2008)
Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy
M. Metz et al.
ALLERGY (2008)
Daclizumab Improves Asthma Control in Patients with Moderate to Severe Persistent Asthma A Randomized, Controlled Trial
William W. Busse et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
One year administration of Anti-IgE to a patient with Churg-Strauss syndrome
Pedro Giavina-Bianchi et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2008)
Alefacept (lymphocyte function-associated molecule 3/IgG fusion protein) treatment for atopic eczema
Dagmar Simon et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Anti-CD20 (rituximab) treatment for atopic eczema
Anna Sediva et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Omalizumab and Churg-Strauss syndrome
Pedro Giavina-Bianchi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Anti-CD20 (rituximab) treatment improves atopic eczema
Dagmar Simon et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Treatment of chronic autoimmune urticaria with omalizumab
Allen P. Kaplan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Churg-strauss vasculitis in a patient treated with omalizumab
Elana Bargagli et al.
JOURNAL OF ASTHMA (2008)
Alefacept for moderate to severe atopic dermatitis: A pilot study in adults
Danielle K. Moul et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Treatment of patients with the hypereosinophilic syndrome with mepolizumab
Marc E. Rothenberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Steroid-sparing effect of Omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis
Jacquelyn M. Zirbes et al.
PEDIATRIC PULMONOLOGY (2008)
The role of a soluble TNFα receptor fusion protein (etanercept) in corticosteroid refractory asthma:: a double blind, randomised, placebo controlled trial
J. B. Morjaria et al.
THORAX (2008)
Apparent response to anti-IgE therapy in two patients with refractory forme fruste'' of Churg-Strauss syndrome
S. Pabst et al.
THORAX (2008)
A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma
Patrick Flood-Page et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels
Benedetta Belloni et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Effect of an interieukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies
Sally Wenzel et al.
LANCET (2007)
The role of anti-IgE immunoglobulin therapy in nasal polyposis: A pilot study
Renee Penn et al.
AMERICAN JOURNAL OF RHINOLOGY (2007)
Lack of response of severe steroid-dependent chronic urticaria to rituximab
R. Mallipeddi et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2007)
Efalizumab for severe atopic dermatitis: A pilot study in adults
Rodd Takiguchi et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Safety of anti-immunoglobulin E therapy with omalizumab in allergic patients at risk of geohelminth infection
A. A. Cruz et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2007)
Successful treatment of delayed pressure urticaria with anti-TNF-alpha
Markus Magerl et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: Inhibition of IgE-facilitated allergen binding
Sven Klunker et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis
Miguel L. Stein et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps
Philippe Gevaert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
被撤回的出版物: The effects of a monoclonal antibody directed against tumor necrosis factor-α in asthma (Retracted article. See vol. 183, pg. 418, 2011)
Edward M. Erin et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Safety of extended treatment with anakinra in patients with rheumatoid arthritis
R. M. Fleischmann et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE
Joshua A. Boyce
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Evidence of a role of tumor necrosis factor α in refractory asthma
MA Berry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis
TB Casale et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Regulation of innate and adaptive immune responses by the related cytokines IL-12, IL-23, and IL-27
C Beadling et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2006)
No effect of anti-interleukin-5 therapy (mepolizumab) on the atopy patch test in atopic dermatitis patients
J. M. Oldhoff et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2006)
Tumour necrosis factor (TNFα) as a novel therapeutic target in symptomatic corticosteroid dependent asthma
PH Howarth et al.
THORAX (2005)
Etanercept is minimally effective in 2 children with atopic dermatitis
RL Buka et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)
Anti-IL-5 recombinant humanized monoclonal antibody (Mepolizumab) for the treatment of atopic dermatitis
JM Oldhoff et al.
ALLERGY (2005)
Infliximab in the treatment of moderate to severe atopic dermatitis
A Jacobi et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)
Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment):: INNOVATE
M Humbert et al.
ALLERGY (2005)
Safety and efficacy of the monoclonal anti-interleukin-5 antibody SCH55700 in the treatment of patients with hypereosinophihc syndrome
AD Klion et al.
BLOOD (2004)
Omalizumab-induced reductions in mast cell FcεRI expression and function
LA Beck et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis
S Plotz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis
J Kuehr et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
Effect of omalizumab on symptoms of seasonal allergic rhinitis - A randomized controlled trial
TB Casale et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Efficacy of soluble IL-4 receptor for the treatment of adults with asthma
LC Borish et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis
E Ädelroth et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2000)
分享论文
